Related Articles
Luteinizing hormone inhibits cisplatin‑induced apoptosis in human epithelial ovarian cancer cells
Synergistic antitumor effects of liposomal honokiol combined with cisplatin in colon cancer models
TREATMENT WITH LUTEINIZING-HORMONE-RELEASING HORMONE ANTAGONIST SB-75 DECREASES LEVELS OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND ITS MESSENGER-RNA IN OV-1063 HUMAN EPITHELIAL OVARIAN-CANCER XENOGRAFTS IN NUDE-MICE
Downregulation of ITIH3 contributes to cisplatin‑based chemotherapy resistance in ovarian carcinoma via the Bcl‑2 mediated anti‑apoptosis signaling pathway
Down-regulation and change in subcellular distribution of receptors for luteinizing hormone-releasing hormone in OV-1063 human epithelial ovarian cancers during therapy with LH-RH antagonist Cetrorelix.